Published in AIDS Weekly, December 5th, 2005
According to recent research from Germany, "Sequence variations in the gp41 heptad repeat 1 (HR1) region have been identified in some treatment-naive HIV-1-infected patients, but it remained elusive whether they confer resistance to fusion inhibitors."
"[Our objective was] to evaluate whether naturally occurring sequence variations in the HIV-1 group M gp41 HRI region affect the sensitivity to inhibition by T-20 and T-1249."
"Site-directed mutagenesis was used to generate HIV-1 NL4-3 mutants containing changes in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.